Potential mechanisms of ticagrelor in modulating neurodegeneration in rotenone-induced parkinsonism in rats / (Record no. 175528)

MARC details
000 -LEADER
fixed length control field 05603namaa22004571i 4500
003 - CONTROL NUMBER IDENTIFIER
control field EG-GICUC
005 - أخر تعامل مع التسجيلة
control field 20251105105255.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 251104s2025 ua a|||frm||| 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloguing agency EG-GICUC
Language of cataloging eng
Transcribing agency EG-GICUC
Modifying agency EG-GICUC
Description conventions rda
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
Language code of summary or abstract eng
-- ara
049 ## - Acquisition Source
Acquisition Source Deposit
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC)
Classification number 615.1
Edition number 21
097 ## - Degree
Degree Ph.D
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Local Call Number Cai01.08.09.Ph.D.2025.Mu.P
100 0# - MAIN ENTRY--PERSONAL NAME
Authority record control number or standard number Muhammad Muneeb Muhammad Abdulazeem,
Preparation preparation.
245 10 - TITLE STATEMENT
Title Potential mechanisms of ticagrelor in modulating neurodegeneration in rotenone-induced parkinsonism in rats /
Statement of responsibility, etc. by Muhammad Muneeb Muhammad Abdulazeem ; Supervision Dr. Dalaal Moustafa Abdallah, Dr. Hanan Salah El-Din El-Abhar, Dr. Walaa Wadie Ibrahim, Dr. Yasmin Saad Abulfadl.
246 15 - VARYING FORM OF TITLE
Title proper/short title آليات تيكاجريلورالممكنه في تخفيفالإنتكاس العصبي المُحدث في الجرذان المصابة بالشلل الرعاش المُحدث بالروتينون
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 2025.
300 ## - PHYSICAL DESCRIPTION
Extent 107 pages :
Other physical details illustrations ;
Dimensions 25 cm. +
Accompanying material CD.
336 ## - CONTENT TYPE
Content type term text
Source rda content
337 ## - MEDIA TYPE
Media type term Unmediated
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Source rdacarrier
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D)-Cairo University, 2025.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Bibliography: pages 78-107.
520 #3 - SUMMARY, ETC.
Summary, etc. Cardiovascular diseases, such as myocardial infarction, ischemic stroke, and coronary heart ailments have been closely associated with Parkinson’s disease (PD). Despite this established link, the potential neuroprotective impact of the potent antiplatelet agent ticagrelor (Tica) remains unexplored against PD. Thus, we hypothesized that Tica could be repurposed as a therapeutic agent against PD. <br/> The rotenone experimental model was adopted in Wistar male rats by administering rotenone subcutaneously on alternate days during a 21-day experimental period and treating a subset of rats with Tica orally for the last 11 consecutive days.<br/> The administration of Tica improved motor function (open field test, hanging wire test) and restored striatal histological features. Additionally, Tica opposed the rotenone effect and markedly obliterated the striatal alpha-synuclein content but enhanced the protein expression of tyrosine hydroxylase and dopamine content. On the molecular level, Tica inhibited striatal endoplasmic reticulum stress (ERS) as evidenced by the downregulation of the ER-resident transmembrane sensor inositol-requiring enzyme 1 alpha and its downstream molecular targets, TNF receptor-associated factor 2 and c-Jun N-terminal kinase, along with a reduction in caspase-3 activity. On the other hand, Tica augmented the autophagy machinery by upregulating the autophagosome markers Beclin-1 and light chain 3-II, while inhibiting the content of cathepsin-D.<br/> Therefore, the current study is the first to accentuate the neuroprotective potential of Tica in a rat model of PD via modulating the crosstalk between ERS, apoptosis, and autophagy to represent a potential novel therapeutic candidate for managing PD, particularly in patients with or prone to cardiovascular diseases.
520 #3 - SUMMARY, ETC.
Summary, etc. يعد مرض الشلل الرعاش ثاني أكثر الاضطرابات العصبية التنكسية والذي يتميز بالتنكس المستمر للخلايا العصبية الدوبامينية في المادة السوداء مما ينتج عنهنقصللدوبامين و يؤدي إلى صعوبات حركية. لذلك يعد نموذج الروتينون نموذجا جيدًا للدراسات التجريبيةحيث أن السمات المرضية لمرض الشلل الرعاش الناجم عن الروتينون تتشابه إلى حد كبير في العديد من الآليات الخاصة بمرض الشلل الرعاش والتي تشمل إعاقة إشارات الإلتهام الذاتي ونشاطإجهادالشبكة الإندوبلازمية والموت الخلوي، بالإضافة إلى انخفاض مستويات الدوبامين وإنزيم التيروزين هيدروكسيليز، وزيادة مستويات الألفا سينوكيولين.<br/>الجدير بالذكر أن دواء تيكاجريلوريعمل كمضاد لمستقبلات بي ٢ واي ١٢ وله فوائد علاجية عديده حيث يعمل كمضاد للتجلط نتيجة تثبيط تجمع الصفائح الدموية.وبالإضافة الى ذلك أثبت هذا الدواء خواصه كمضاد للإلتهابات وللإلتهام الذاتي وللأكسدة من خلال مسارات إشارات مختلفة. تقع مستقبلات بي ٢ واي ١٢ في العديد من المواقع المركزية بما في ذلك الجسم الثفني والحُصين والمادة السوداءوالمهاد.
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Issues CD Issues also as CD.
546 ## - LANGUAGE NOTE
Text Language Text in English and abstract in Arabic & English.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element العقاقير
653 #1 - INDEX TERM--UNCONTROLLED
Uncontrolled term Ticagrelor
-- Rotenone
-- Parkinson's disease
-- Endoplasmic-reticulum stress
-- Apoptosis
-- Autophagy
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Dalaal Moustafa Abdallah
Relator term thesis advisor.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Hanan Salah El-Din El-Abhar
Relator term thesis advisor.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Walaa Wadie Ibrahim
Relator term thesis advisor.
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Yasmin Saad Abulfadl
Relator term thesis advisor.
900 ## - Thesis Information
Grant date 01-01-2025
Supervisory body Dalaal Moustafa Abdallah
-- Hanan Salah El-Din El-Abhar
-- Walaa Wadie Ibrahim
-- Yasmin Saad Abulfadl
Universities Cairo University
Faculties Faculty of Pharmacy
Department Department of Pharmacology & Toxicology
905 ## - Cataloger and Reviser Names
Cataloger Name Shimaa
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
Edition 21
Suppress in OPAC No
Holdings
Source of classification or shelving scheme Home library Current library Date acquired Inventory number Full call number Barcode Date last seen Effective from Koha item type
Dewey Decimal Classification المكتبة المركزبة الجديدة - جامعة القاهرة قاعة الرسائل الجامعية - الدور الاول 04.11.2025 92370 Cai01.08.09.Ph.D.2025.Mu.P 01010110092370000 04.11.2025 04.11.2025 Thesis
Cairo University Libraries Portal Implemented & Customized by: Eng. M. Mohamady Contacts: new-lib@cl.cu.edu.eg | cnul@cl.cu.edu.eg
CUCL logo CNUL logo
© All rights reserved — Cairo University Libraries
CUCL logo
Implemented & Customized by: Eng. M. Mohamady Contact: new-lib@cl.cu.edu.eg © All rights reserved — New Central Library
CNUL logo
Implemented & Customized by: Eng. M. Mohamady Contact: cnul@cl.cu.edu.eg © All rights reserved — Cairo National University Library